Genes are the language of life. Understanding that language is made difficult by the volume of information generated by today’s genetic testing, and the velocity of clinical research.
MolecularHealth is committed to translating that language into actionable information that doctors and their patients can use to make informed decisions about cancer care, choosing the best and safest treatment options. Our automated analytics platform, based on leading edge technologies from information giant SAP, can interpret terabytes of clinical and genomic data in a fraction of the time of the manual methods currently used by most testing labs, thereby overcoming the bottleneck to faster and more precise treatment.
Backed by one of the world’s most successful information technologists, Dietmar Hopp, the co-founder and former chairman and CEO of SAP, MolecularHealth is the result of eight years of development by a multidisciplinary team of doctors, scientists and IT experts and is just now being made available in North America.
Led and managed by M.D.s, Ph.Ds. and healthcare professionals, MolecularHealth works in partnership with some of the world’s leading healthcare and information technology companies, including SAP and MD Anderson Cancer Center, and is the only cancer diagnostic platform in the world integrated with the FDA’s Center for Drug Evaluation and Research, allowing for unprecedented safety.